I agree about the current situation. Consider how much the company has emphasized their previous work on virus vaccine work and how quickly to huge manufacturing they claim they can be. Should BARDA not provide support, I personally would have to take that as the platform holds little promise for now or ever, at least as far as viral vaccines are concerned. Seems to be investors already see it that way. Silence from the company will lead to wild assumptions. Complete opposite of all the hype we had for the years leading up to 2020.